Emtricitabine
-
Subject Areas on Research
- Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.
- Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.
- Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection.
- FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.
- Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.
- HIV drug resistance in a cohort of HIV-infected MSM in the United States.
- HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.
- Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine.
- Kidney injury biomarkers during exposure to tenofovir-based preexposure prophylaxis.
- Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.
- Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.
- Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
- Newer treatments for HIV in children.
- Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP.
- Plasma and Intracellular Concentrations in HIV-Infected Patients Requiring Hemodialysis Dosed With Tenofovir Disoproxil Fumarate and Emtricitabine.
- Pre-exposure prophylaxis works--it's time to deliver.
- Preexposure prophylaxis for HIV infection among African women.
- Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination.
- Tenofovir alafenamide for HIV infection: is less more?
- The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills.
- Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men.
- Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.